GlaxoSmithKline forfeits millions in incentives
Pharmaceutical giant GlaxoSmithKline PLC is forfeiting $1.4 million in state incentives so that it will have the option of cutting jobs at a facility in Zebulon.
After knowingly selling drugs with questionable safety for years, drug maker GlaxoSmithKline has agreed to a $750 million settlement.